A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitis by Atsushi Tanaka, Masanori Abe, Tadashi Namisaki, Shinji Shimoda, Mikio Zeniya, Akio Ido, Hitoshi Yoshiji, Hiromasa Ohira, Kenichi Harada, Yuko Kakuda, Atsushi Umeda, Yuki Kamiya, Yukari Higashine, Seiichiro Hojo, Toshio Imai, Tetsu Kawano, Yasuni Nakanuma, Hirohito Tsubouchi

Get full text